'We've got a lot more to do'

Dr. Halle Moore, Cleveland Clinic and Dr. Dennis Slamon, UCLA's Jonsson Cancer Center on a new way of using the drug Herceptin with other drugs that makes it less risky for women with an especially aggressive form of breast cancer.